Invesco Health Care Fund Investor Class (GTHIX)

Fund Assets	1.21B
Expense Ratio	1.07%
Min. Investment	$1,000
Turnover	59.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 18, 2025

Previous Close	42.20
YTD Return	8.90%
1-Year Return	20.53%
5-Year Return	17.26%
52-Week Low	35.17
52-Week High	43.00
Beta (5Y)	n/a
Holdings	80
Inception Date	n/a

About GTHIX

Invesco Health Care Fund Investor Class is an equity mutual fund focused on achieving long-term capital growth by investing primarily in the securities of companies engaged in the health care sector worldwide. The fund allocates at least 80% of its net assets to health care-related industries, including common and preferred stocks as well as depositary receipts. Its diversified portfolio spans various market capitalizations, with significant exposure to small- and mid-cap companies. The fund employs a bottom-up, fundamental stock-picking approach to select growth-oriented equities across multiple health care sub-sectors, such as biotechnology, pharmaceuticals, medical devices, and health services. Notable holdings typically include leading industry names like Boston Scientific, Eli Lilly, and AbbVie. With a broad global perspective, the fund aims to participate in the growth dynamics of the health care industry, which is characterized by innovation, demographic trends, and regulatory influences. This strategy positions the fund as a vehicle for investors seeking targeted exposure to the health care sector within a diversified equity framework.

• Fund Family: Invesco
• Category: Health
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: GTHIX
• Share Class: Investor Class

Performance

GTHIX had a total return of 20.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.05%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
GGHYX	Class Y	0.82%
GGHCX	Class A	1.07%
GTHRX	Class R	1.32%
GTHCX	Class C	1.82%

Top 10 Holdings

46.66% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	10.84%
Johnson & Johnson	JNJ	6.32%
UnitedHealth Group Incorporated	UNH	6.06%
Merck & Co., Inc.	MRK	4.18%
argenx SE	ARGX	3.99%
AbbVie Inc.	ABBV	3.96%
Gilead Sciences, Inc.	GILD	3.46%
AstraZeneca PLC	AZN	2.90%
BrightSpring Health Services, Inc.	BTSG	2.73%
Welltower Inc.	WELL	2.22%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$2.2025	Dec 18, 2025
Dec 16, 2024	$1.8353	Dec 16, 2024
Dec 16, 2021	$9.9297	Dec 16, 2021
Dec 15, 2020	$0.4737	Dec 15, 2020
Dec 13, 2019	$1.4728	Dec 13, 2019
Dec 14, 2018	$2.9024	Dec 14, 2018

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error